113 related articles for article (PubMed ID: 37786948)
81. [Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer].
Rogala E; Nowicka A; Bednarek W; Barczyński B; Wertel I; Zakrzewski M; Kotarski J
Ginekol Pol; 2012 Jun; 83(6):424-8. PubMed ID: 22880461
[TBL] [Abstract][Full Text] [Related]
82. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C.
Osuch S; Laskus T; Berak H; Perlejewski K; Metzner KJ; Paciorek M; Radkowski M; Caraballo Cortés K
Sci Rep; 2020 Sep; 10(1):16060. PubMed ID: 32994477
[TBL] [Abstract][Full Text] [Related]
83. SLAM-SAP signaling promotes differentiation of IL-17-producing T cells and progression of experimental autoimmune encephalomyelitis.
Huang YH; Tsai K; Ma C; Vallance BA; Priatel JJ; Tan R
J Immunol; 2014 Dec; 193(12):5841-53. PubMed ID: 25362182
[TBL] [Abstract][Full Text] [Related]
84. Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer.
Handa Y; Tsutani Y; Shiroma N; Kai Y; Mimae T; Miyata Y; Takeshima Y; Arihiro K; Okada M
Clin Lung Cancer; 2020 Jul; 21(4):e302-e314. PubMed ID: 32102750
[TBL] [Abstract][Full Text] [Related]
85. Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model.
Saxena A; Desbois S; Carrié N; Lawand M; Mars LT; Liblau RS
J Immunol; 2012 Sep; 189(6):3140-9. PubMed ID: 22904307
[TBL] [Abstract][Full Text] [Related]
86. Cell origins and significance of IL-17 in malignant pleural effusion.
Gong Y; Chen SX; Gao BA; Yao RC; Guan L
Clin Transl Oncol; 2014 Sep; 16(9):807-13. PubMed ID: 24399072
[TBL] [Abstract][Full Text] [Related]
87. Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8
Rolig AS; Rose DC; McGee GH; Rubas W; Kivimäe S; Redmond WL
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35444059
[TBL] [Abstract][Full Text] [Related]
88. Polyfunctional, Proinflammatory, Tissue-Resident Memory Phenotype and Function of Synovial Interleukin-17A+CD8+ T Cells in Psoriatic Arthritis.
Steel KJA; Srenathan U; Ridley M; Durham LE; Wu SY; Ryan SE; Hughes CD; Chan E; Kirkham BW; Taams LS
Arthritis Rheumatol; 2020 Mar; 72(3):435-447. PubMed ID: 31677365
[TBL] [Abstract][Full Text] [Related]
89. Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model.
Ueyama A; Imura C; Fusamae Y; Tsujii K; Furue Y; Aoki M; Suzuki M; Okuda T; Oshima I; Yasui K; Shichijo M; Yamamoto M
J Dermatol Sci; 2017 Jan; 85(1):27-35. PubMed ID: 27810232
[TBL] [Abstract][Full Text] [Related]
90. Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8
Cheng CC; Ho AS; Peng CL; Chang J; Sie ZL; Wang CL; Chen YL; Chen CY
Int Immunopharmacol; 2022 Nov; 112():109110. PubMed ID: 36037651
[TBL] [Abstract][Full Text] [Related]
91. IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8
Dadaglio G; Fayolle C; Oberkampf M; Tang A; Rudilla F; Couillin I; Torheim EA; Rosenbaum P; Leclerc C
Oncoimmunology; 2020 May; 9(1):1758606. PubMed ID: 32923117
[TBL] [Abstract][Full Text] [Related]
92. IL-17A-producing T cells and associated cytokines are involved in the progression of gastric cancer.
Zhong F; Cui D; Tao H; Du H; Xing C
Oncol Rep; 2015 Nov; 34(5):2365-74. PubMed ID: 26352729
[TBL] [Abstract][Full Text] [Related]
93. Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells.
Nanjappa SG; Heninger E; Wüthrich M; Gasper DJ; Klein BS
PLoS Pathog; 2012; 8(7):e1002771. PubMed ID: 22829762
[TBL] [Abstract][Full Text] [Related]
94. [Clinical features of imbalance between Th1 and Th22 cells and its association with disease progression in patients with liver cirrhosis].
Wu HQ; Zhao JJ; Li HW; Zhang Z
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):738-744. PubMed ID: 29108201
[No Abstract] [Full Text] [Related]
95. Blockade of PD-1 and LAG-3 expression on CD8+ T cells promotes the tumoricidal effects of CD8+ T cells.
Ma J; Yan S; Zhao Y; Yan H; Zhang Q; Li X
Front Immunol; 2023; 14():1265255. PubMed ID: 37841254
[TBL] [Abstract][Full Text] [Related]
96. Friend or Foe - Tc17 cell generation and current evidence for their importance in human disease.
Hipp AV; Bengsch B; Globig AM
Discov Immunol; 2023; 2(1):kyad010. PubMed ID: 38567057
[TBL] [Abstract][Full Text] [Related]
97. Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL-17 expression associated with cancer relapse.
Gies S; Melchior P; Stroeder R; Tänzer T; Theobald L; Pohlers M; Glombitza B; Sester M; Solomayer EF; Walch-Rückheim B
Int J Cancer; 2024 Jan; 154(2):343-358. PubMed ID: 37786948
[TBL] [Abstract][Full Text] [Related]
98. CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer.
Chellappa S; Hugenschmidt H; Hagness M; Subramani S; Melum E; Line PD; Labori KJ; Wiedswang G; Taskén K; Aandahl EM
J Immunol; 2017 Feb; 198(4):1729-1739. PubMed ID: 28053236
[TBL] [Abstract][Full Text] [Related]
99. Identification of CD8
Perdomo-Celis F; Arcia-Anaya D; Alzate JC; Velilla PA; Díaz FJ; Posada MP; Rugeles MT; Taborda NA
AIDS Res Ther; 2022 Sep; 19(1):42. PubMed ID: 36104716
[TBL] [Abstract][Full Text] [Related]
100. Long-term prognostic significance of interleukin-17-producing T cells in patients with non-small cell lung cancer.
Song L; Ma S; Chen L; Miao L; Tao M; Liu H
Cancer Sci; 2019 Jul; 110(7):2100-2109. PubMed ID: 31100180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
